Synpromics

gainesville-fl

AGTC and Synpromics Limited Announce R&D Collaboration to Develop Synthetic Promoters for Enhanced Gene Therapy Candidates

Applied Genetic Technologies Corporation a biotechnology company conducting human clinical trials of adeno-associated virus-based gene therapies for the treatment of rare eye diseases, and Synpromics Limited, a leading synthetic promoter development company backed by Calculus Capital, announced they have entered into a broad, multi-target collaboration agreement. Potential payments to be made by AGTC to Synpromics...

Technology. Finance. Real estate. The startup scene. As Gainesville’s business dynamics booms, local leaders and entrepreneurs are looking to the Business Report for news and advice. The Business Report is a print and online publication that strives to produce timely editorial content relevant to our business-oriented audience and follows the historic rules of journalism.